MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-HR-01-0000733
Solace Biotech Limited - pharma in Saha, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹7.14 Cr
▼ 8% YoY
Net profit · FY 2024
₹2.87 Lakh
Net margin 0.4%
EBITDA · FY 2024
₹1.15 Cr
EBITDA margin 16.1%
Authorised capital
₹30 Lakh
Registered with MCA
Paid-up capital
₹30 Lakh
Issued & subscribed
Open charges
₹9.05 Cr
Satisfied ₹5.61 Cr
Company age
13 yrs
Est. 2013
Employees · EPFO
10
Provident fund records
About Solace Biotech Limited
Data last updated:
Solace Biotech Limited is a public limited company based in Saha, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 July 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24232HR2013PLC049887. Its GSTIN is 06AATCS3925J1ZU (Haryana). The company holds 5 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹30 Lakh. It is led by directors including Kamal Chawla and Raman Chawla.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 195 Sector – 2 Phase – 1 Food Park Industrial Estate, Saha, Haryana, India – 133104.
As per the financials filed for FY 2024, the company reported a revenue of ₹7.14 Cr, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹2.87 Lakh (net margin 0.4%) and EBITDA of ₹1.15 Cr (EBITDA margin 16.1%). Revenue has declined at a compounded annual rate (CAGR) of 19% over three years and 7% over five years.
The company has about 10 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Solace Biotech Limited. As per MCA filings, the company has open charges of ₹9.05 Cr and satisfied charges of ₹5.61 Cr on record. Court records list 6 cases involving the company, including 2 filed by the company and 4 filed against it; 1 case is pending.
Solace Biotech Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-01-0000733). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website solacebiotech.in.
Company details
CIN U24232HR2013PLC049887
Registration Number 049887
Incorporation Date 22 July 2013
ROC Haryana
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-HR-01-0000733
Recognitions & Rankings of Solace Biotech
Contact details
Solace Biotech Limited's registered office is in Saha, Haryana. Its website is solacebiotech.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No. 195 Sector – 2 Phase – 1 Food Park Industrial Estate, Saha, Haryana, India – 133104
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Solace Biotech Limited, buy the company report.
Comprehensive company report
Solace Biotech Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Solace Biotech operates one associated brand: Solace Biotech Limited. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical and Ayurvedic product manufacturing, along with franchise and third-party services in India. | solacebiotech.in |
Business activity
The main business activity of Solace Biotech is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Solace Biotech Limited, buy the company report.
Financials of Solace Biotech Limited
FY 2025 filings availableSolace Biotech Limited reported revenue of ₹7.14 Cr (down 8% YoY) for FY 2024.
Revenue · FY 2024
₹7.14 Cr ▼ 8%
Net profit · FY 2024
₹2.87 Lakh margin 0.4%
EBITDA · FY 2024
₹1.15 Cr margin 16.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 8%
3 years · compounded
▼ 19%
5 years · compounded
▼ 7%
EBITDA CAGR growth
1 year
▲ 1%
3 years · compounded
▼ 2%
5 years · compounded
▲ 4%
Revenue has declined at a compounded annual rate (CAGR) of 7% over five years, including a 8% fall in the latest year. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.15 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.87 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16.1% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Solace Biotech Limited, buy the company report.
Board of directors of Solace Biotech Limited
Solace Biotech has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kamal Chawla | Director | 22 Jul 2013 | 13 Years 3 Months | Current |
| Raman Chawla | Director | 22 Jul 2013 | 13 Years 3 Months | Current |
| Rohit Gupta | Director | 24 Dec 2022 | 3 Years 9 Months | Current |
Peer comparison
Solace Biotech Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lemford Biotech Private Limited | ₹7.17 Cr (FY 2025) | 4.0% | Meerut, Uttar Pradesh, India | |||
| Everwell Pharma Private Limited | ₹7.16 Cr (FY 2024) | -7.0% | Chandigarh, India | |||
| Solace Biotech Limitedthis company | ₹7.14 Cr (FY 2024) | ₹2.87 Lakh | 0.4% | -8.0% | 10 | Saha, Haryana, India |
| Worth Medicines India Private Limited | ₹7.12 Cr (FY 2024) | 2.0% | Himachal Pradesh, India | |||
| Priority Pharmaceuticals Private Limited | ₹7.12 Cr (FY 2025) | 174.0% | Jaipur, Rajasthan, India |
To see the full peer comparison of Solace Biotech Limited, buy the company report.
Auditor
Solace Biotech Limited is audited by Srivastava V K & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Srivastava V K & Associates | FY 2023 | 405765 |
Shareholding
The shareholding of Solace Biotech Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Solace Biotech Limited, buy the company report.
Charges & borrowings
Open charges
₹9.05 Cr
Satisfied charges
₹5.61 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 May 2025 | 101108269 | Others | ₹3.85 Cr | Open | |
| 22 Dec 2022 | 100703070 | Others | ₹3.7 Cr | Open | |
| 22 Dec 2022 | 100703084 | Others | ₹26.2 Lakh | Open | |
| 22 Dec 2022 | 100703096 | Others | ₹17.5 Lakh | Open | |
| 22 Dec 2022 | 100704402 | Others | ₹32 Lakh | Open |
To see the full charge records of Solace Biotech Limited, buy the company report.
Total charge records: 11 View all charges
Legal cases
Solace Biotech Limited has 6 court cases on record: 2 filed by Solace Biotech, 4 filed against it. 1 case is pending and 5 are disposed.
Total cases
6
Filed by the company
2
Filed against the company
4
Pending
1
Disposed
5
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 4 | 0 |
| High courts | 1 | 0 | 1 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Gurugram, Haryana | Cheque dishonour complaint | Filed against the company by Dhani Loans and Services Ltd | Disposed |
| District court, Central, Delhi | Interim or miscellaneous application | Filed against the company by Rapross Pharmaceuticals (P) Ltd. | Disposed |
| High Court | Writ petition | Filed by the company against Haryana Micro and Small Enterprises Facilitation Council and Ors. and 2 others | Pending |
| District court, Ambala, Haryana | Execution petition | Filed against the company by an individual | Disposed |
| District court, Ambala, Haryana | Civil suit | Filed against the company by an individual | Disposed |
To see the full case history of Solace Biotech Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Solace Biotech Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Solace Biotech Limited has a workforce of 10 employees on its EPFO records as of Oct 08, 2025, across 1 active EPFO establishment.
Employee count
10
Active EPFO establishments
1
Employee growth
-41.18%
GST
Solace Biotech has 5 GST registrations: 3 active and 2 cancelled or inactive.
Total GSTINs
5
Active
3
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AATCS3925J1ZU | Haryana | Active | 01 Jul 2017 |
| 06AATCS3925J2ZT | Haryana | Active | 09 Jun 2020 |
| 05AATCS3925J1ZW | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Solace Biotech Limited, buy the company report.
Recent activity
Solace Biotech Limited has 6 board changes on record since 2013: 3 appointments and 3 cessations. The latest: Satish Kumar ceased to be Director on 26 Dec 2022.
AGM
Solace Biotech Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others of Rs. 385.00 Lakh registered on 27 May 2025 with Charge ID 101108269 was modified on 25 Jul 2025.
Charges
A charge with Others amounted to Rs. 385.00 Lakh with Charge ID 101108269 was registered on 27 May 2025.
Filing
Solace Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Haryana.
Charges
A charge registered on 18 Mar 2021 via Charge ID 100429377 with Others was fully satisfied on 20 Feb 2024.
Charges
A charge registered on 08 Feb 2021 via Charge ID 100417943 with Others was fully satisfied on 20 Feb 2024.
Charges
A charge with Others of Rs. 370.00 Lakh registered on 22 Dec 2022 with Charge ID 100703070 was modified on 10 Jul 2023.
Charges
A charge with Others of Rs. 26.20 Lakh registered on 22 Dec 2022 with Charge ID 100703084 was modified on 10 Jul 2023.
Charges
A charge with Others of Rs. 17.50 Lakh registered on 22 Dec 2022 with Charge ID 100703096 was modified on 10 Jul 2023.
Charges
A charge with Others of Rs. 32.00 Lakh registered on 22 Dec 2022 with Charge ID 100704402 was modified on 10 Jul 2023.
Ceased
Satish Kumar ceased to be Director.
Appointed
Rohit Gupta was appointed as Director.
18 earlier events are in the company report.
Frequently asked questions
Solace Biotech is an active public limited company based in Saha, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 July 2013 (13+ years old) and is registered under CIN U24232HR2013PLC049887.
Solace Biotech has 3 current directors:
- Kamal Chawla - Director
- Raman Chawla - Director
- Rohit Gupta - Director
The latest financial statements of Solace Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Solace Biotech is 06AATCS3925J1ZU, registered in Haryana. The company has 5 GST registrations in all, of which 3 are active and 2 are cancelled or inactive. Other active GSTINs include 06AATCS3925J2ZT (Haryana), 05AATCS3925J1ZW (Uttarakhand).
The CIN (Corporate Identification Number) of Solace Biotech is U24232HR2013PLC049887. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Solace Biotech has 6 court cases on record: 2 filed by the company and 4 filed against it. 1 is pending. Most are in the district courts.
Solace Biotech was incorporated on 22 July 2013, making it 13+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Solace Biotech by revenue are Lemford Biotech Private Limited, Everwell Pharma Private Limited, Worth Medicines India Private Limited, Priority Pharmaceuticals Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Satish Kumar ceased to be Director on 26 Dec 2022. Rohit Gupta was appointed as Director on 24 Dec 2022. Rohit Gupta ceased to be Director on 22 Feb 2020. Solace Biotech has 6 board changes on record in total.
Yes, Solace Biotech is registered as a small enterprise under Udyam registration (number: UDYAM-HR-01-0000733).
Solace Biotech can be reached through the website solacebiotech.in. Its registered office is in Saha, Haryana, India.